Overview

Treatment of Conditions With Open Label-Anecortave Acetate Sterile Suspension ( 15mg.) Where Lesions do Not Meet Acceptable Criteria for Standard Care.

Status:
Completed

Trial end date:
2007-03-01

Target enrollment:

Participant gender:

Summary

A compassionate method of treatment is offered to patients where lesions do not meet acceptable criteria for standard therapy. Visudyne (Photodynamic Therapy) and laser photocoagulation treatment (a treatment using heat from a fine point laser beam) have not been found to be effective in treating the lesions these patients have. Anecortave acetate is an experimental drug that is being tested to prevent the growth of blood vessels under the retina in patients with age-related macular degeneration (AMD).

Phase:

Phase 2

Details

Lead Sponsor:

Manhattan Eye, Ear & Throat Hospital

Collaborator:

Alcon Research

Treatments:

Anecortave